RLS.ST

RLS Global AB (publ) [RLS.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RLS.ST Stock Summary

In the News

RLS.ST Financial details

Company Rating
-
Market Cap
35.62M
Income
-28.98M
Revenue
804K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
25 Aug 2023
P/E
-1.23
Forward P/E
-
PEG
-0.1
P/S
44.31
P/B
2.14
P/C
-
P/FCF
-1.19
Quick Ratio
0.66
Current Ratio
1.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.38
EPS next Y
-
EPS next Q
-
EPS this Y
82.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.48%
Revenue last 5Y
-14.49%
Revenue Q/Q
150.56%
EPS Q/Q
0.43%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-123%
ROE
-133%
ROC
-1.68%
Gross Margin
100%
Oper. Margin
-3462%
Profit Margin
-3605%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.213-3.49
52W High
-
52W Low
-
RSI
-
Rel Volume
0.25
Avg Volume
29.21K
Volume
7.21K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.572
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.446
Change
-0.89%

Something similar

Top by Market Cap
META
NVDA
EMBASSY.NS
AMZ.DE
BRK-A
Same Sector
ACARIX.ST
294090.KQ
PTE
GLASF
IDXG
Check Those
CLW
FMN
TGBHOTELS.NS
GTPAW
HEWA
Similar Market Cap
GCM.L
8206.HK
ELVT
HLFN
KBT.L

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 29.21K
  • Market Capitalization 35.62M
  • Employee 9
  • CEO Dr. Roland Frosing M.D., Ph.D.
  • Headquarters Mölndal,SE
  • IPO Date 2005-07-11
  • Website https://rls.global

RLS Global AB (publ), a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. The company was founded in 1996 and is based in Mölndal, Sweden.